PMID: 9431998Feb 7, 1998Paper

P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer

European Journal of Biochemistry
A B ShapiroV Ling

Abstract

High-level expression of P-glycoprotein, a 170-kDa mammalian plasma membrane ATPase, is the cause of an important and widespread form of cancer multidrug resistance. P-glycoprotein reduces cellular accumulation of an enormous variety of lipophilic compounds. The basis for this broad substrate specificity is not well understood. We explored this issue by measuring the kinetics of transport of the lipophilic P-glycoprotein substrate Hoechst 33342 by P-glycoprotein-rich plasma membrane vesicles from CH(R)B30 cells. Hoechst 33342 is fluorescent when bound to the membrane, but not when in the aqueous medium, allowing movement of the dye out of the membrane to be quantitated by fluorescence intensity. The initial specific rate of transport was directly proportional to the amount of Hoechst 33342 in the lipid phase and inversely proportional to the concentration in the aqueous phase. This demonstrates that P-glycoprotein removes Hoechst 33342 from the lipid membrane, where it concentrates due to its hydrophobicity. Because the membrane concentration of hydrophobic P-glycoprotein substrates is high, it may be that P-glycoprotein need not recognize them with high affinity. Transport of hydrophobic substrates out of the lipid bilayer ins...Continue Reading

References

Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A R Safa
Jan 1, 1982·Methods in Enzymology·C C Goodno
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M E LalandeR G Miller
Jul 7, 1995·The Journal of Biological Chemistry·A B Shapiro, V Ling
Feb 1, 1995·Journal of Bioenergetics and Biomembranes·A B Shapiro, V Ling
Aug 18, 1995·The Journal of Biological Chemistry·I L UrbatschA E Senior
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·G A AltenbergL Reuss
Feb 2, 1996·The Journal of Biological Chemistry·J E MetherallK Waugh
Feb 7, 1998·European Journal of Biochemistry·A B Shapiro, V Ling

❮ Previous
Next ❯

Citations

May 29, 2000·Journal of Cellular Physiology·W Zhang, V Ling
May 13, 2006·Journal of Bioenergetics and Biomembranes·Marwan K Al-Shawi, Hiroshi Omote
Mar 31, 2000·Pharmacology & Therapeutics·H W van VeenW N Konings
Mar 31, 2000·Pharmacology & Therapeutics·A K LarsenA Skladanowski
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S P HämmerleH Wunderli-Allenspach
Feb 9, 2000·Trends in Biochemical Sciences·E E ZheleznovaR G Brennan
Jul 24, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Parjit Kaur
Jun 14, 2000·Current Opinion in Microbiology·W N KoningsB Poolman
Aug 27, 2011·Journal of the American Chemical Society·Hilda A NamanjaJean Chmielewski
Mar 17, 2001·British Journal of Pharmacology·K BogmanJ Drewe
Jul 28, 2005·Natural Product Reports·Kate P LangtonRichard B Herbert
Feb 7, 1998·European Journal of Biochemistry·A B Shapiro, V Ling
Feb 7, 1998·European Journal of Biochemistry·A B Shapiro, V Ling
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·M PutmanW N Konings
Jan 12, 2007·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Frances J Sharom
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Jul 25, 2008·American Journal of Physiology. Cell Physiology·Siying YeBruce A Stanton
Jun 6, 2008·American Journal of Physiology. Cell Physiology·Vishal S NarangChristopher M Waters
Feb 2, 2013·Clinical and Translational Medicine·Lissa Nurrul Abdullah, Edward Kai-Hua Chow
May 23, 2002·Analytical Biochemistry·Alexia GarriguesEric Ezan
Sep 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·James P SáenzKai Simons
Jul 27, 2010·Advanced Drug Delivery Reviews·Dan W UrryMichal Nowicki
Dec 18, 2015·BBA Clinical·Elma A O'ReillyAmanda McCann
Oct 17, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Christel A S BergströmAnja Sandström
Feb 20, 2014·Environmental Microbiology·Ainhoa Revilla-GuarinosManuel Zúñiga
Nov 18, 2015·Journal of Chemical Theory and Computation·Ricardo J FerreiraDaniel J V A Dos Santos
Jan 27, 2009·Biochimica Et Biophysica Acta·Cristina TorresJean-Michel Jault
Jun 11, 2015·Future Medicinal Chemistry·Ricardo J FerreiraMaria-José U Ferreira
Apr 15, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Cornelius CilliersGreg M Thurber
Aug 10, 2010·Biochimica Et Biophysica Acta·László HomolyaBalázs Sarkadi
May 14, 2016·International Journal for Parasitology·Thangadurai ManiRoger K Prichard
Dec 23, 2016·Nature Communications·Hundeep KaurClemens Glaubitz
Jul 20, 2004·Journal of Lipid Research·Szabolcs ModokRichard Callaghan
Aug 4, 2015·Physical Chemistry Chemical Physics : PCCP·Ricardo J FerreiraDaniel J V A dos Santos
Jan 23, 2018·Cell Death Discovery·Daniela CarlisiGiovanni Tesoriere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.